肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

皮肤鳞状细胞癌诊疗专家共识(2021)

2021-08-30 中华医学会皮肤性病学分会 中华皮肤科杂志

皮肤鳞状细胞癌

皮肤鳞状细胞癌是非黑素瘤皮肤癌中最常见的肿瘤之一。近年来随着对其发病机制研究的深入以及诊断技术、Mohs显微描记手术、靶向治疗、免疫治疗的发展，皮肤鳞状细胞癌的诊疗取得了较大进展。

中文标题：

皮肤鳞状细胞癌诊疗专家共识(2021)

发布机构：

中华医学会皮肤性病学分会

发布日期：

2021-08-30

简要介绍：

皮肤鳞状细胞癌是非黑素瘤皮肤癌中最常见的肿瘤之一。近年来随着对其发病机制研究的深入以及诊断技术、Mohs显微描记手术、靶向治疗、免疫治疗的发展，皮肤鳞状细胞癌的诊疗取得了较大进展。该共识在国内外近期文献及诊疗指南的基础上，结合我国的诊疗现状，重点阐述皮肤鳞状细胞癌的临床表现及分型、病理活检及报告规范、风险等级评估、分级分期以及规范化治疗等，为临床医生的诊疗工作提供参考依据。

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2097401, encodeId=b09c209e40167, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a268403758, createdName=ms4000000914158767, createdTime=Sat Oct 29 23:50:37 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205826, encodeId=cdd712058261f, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:35:42 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188043, encodeId=1e34118804371, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e9f4734705, createdName=524140847, createdTime=Tue Jan 25 15:48:39 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079315, encodeId=233d10e9315a0, content=乚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32845001268, createdName=188616968, createdTime=Sun Dec 12 20:28:38 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063815, encodeId=17891063815ce, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e785468679, createdName=ms8000001538123932, createdTime=Mon Oct 25 17:06:19 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-10-29 ms4000000914158767

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2097401, encodeId=b09c209e40167, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a268403758, createdName=ms4000000914158767, createdTime=Sat Oct 29 23:50:37 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205826, encodeId=cdd712058261f, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:35:42 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188043, encodeId=1e34118804371, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e9f4734705, createdName=524140847, createdTime=Tue Jan 25 15:48:39 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079315, encodeId=233d10e9315a0, content=乚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32845001268, createdName=188616968, createdTime=Sun Dec 12 20:28:38 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063815, encodeId=17891063815ce, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e785468679, createdName=ms8000001538123932, createdTime=Mon Oct 25 17:06:19 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-03-25 ms7000001074540642

    👍👍👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2097401, encodeId=b09c209e40167, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a268403758, createdName=ms4000000914158767, createdTime=Sat Oct 29 23:50:37 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205826, encodeId=cdd712058261f, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:35:42 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188043, encodeId=1e34118804371, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e9f4734705, createdName=524140847, createdTime=Tue Jan 25 15:48:39 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079315, encodeId=233d10e9315a0, content=乚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32845001268, createdName=188616968, createdTime=Sun Dec 12 20:28:38 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063815, encodeId=17891063815ce, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e785468679, createdName=ms8000001538123932, createdTime=Mon Oct 25 17:06:19 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-01-25 524140847

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2097401, encodeId=b09c209e40167, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a268403758, createdName=ms4000000914158767, createdTime=Sat Oct 29 23:50:37 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205826, encodeId=cdd712058261f, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:35:42 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188043, encodeId=1e34118804371, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e9f4734705, createdName=524140847, createdTime=Tue Jan 25 15:48:39 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079315, encodeId=233d10e9315a0, content=乚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32845001268, createdName=188616968, createdTime=Sun Dec 12 20:28:38 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063815, encodeId=17891063815ce, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e785468679, createdName=ms8000001538123932, createdTime=Mon Oct 25 17:06:19 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-12-12 188616968

    乚好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2097401, encodeId=b09c209e40167, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a268403758, createdName=ms4000000914158767, createdTime=Sat Oct 29 23:50:37 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205826, encodeId=cdd712058261f, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe306388685, createdName=ms7000001074540642, createdTime=Fri Mar 25 11:35:42 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188043, encodeId=1e34118804371, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e9f4734705, createdName=524140847, createdTime=Tue Jan 25 15:48:39 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079315, encodeId=233d10e9315a0, content=乚好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32845001268, createdName=188616968, createdTime=Sun Dec 12 20:28:38 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063815, encodeId=17891063815ce, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e785468679, createdName=ms8000001538123932, createdTime=Mon Oct 25 17:06:19 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-10-25 ms8000001538123932

    谢谢

    0

相关指南

2020 欧洲跨学科指南：皮肤侵袭性鳞状细胞癌—流行病学，诊断和预防

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2020-02-26

2017 AAD指南：皮肤鳞状细胞癌的管理

美国皮肤病学会(AAD,American Academy of Dermatology) · 2018-01-04

EADV：2011皮肤鳞状细胞癌和前体病变诊断和治疗指南

欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and Venereology) · 2011-07-02